Martingale Asset Management’s Prothena PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$705K Buy
84,116
+5,316
+7% +$47.5K 0.02% 602
2026
Q2
$771K Buy
78,800
+9,699
+14% +$95.8K 0.02% 581
2026
Q1
$672K Buy
69,101
+5,648
+9% +$51.8K 0.02% 585
2025
Q4
$606K Buy
+63,453
New +$646K 0.02% 571
2023
Q4
– Sell
-12,415
Closed -$599K – 837
2023
Q3
$599K Buy
12,415
+1,097
+10% +$65.2K 0.01% 567
2023
Q2
$773K Buy
+11,318
New +$730K 0.02% 520
2020
Q4
– Sell
-44,635
Closed -$446K – 1015
2020
Q3
$446K Sell
44,635
-60,700
-58% -$730K 0.01% 841
2020
Q2
$1.1M Buy
+105,335
New +$1.17M 0.01% 711
2015
Q2
– Sell
-7,301
Closed -$279K – 895
2015
Q1
$279K Buy
+7,301
New +$187K 0.01% 791

Other funds holding PRTA

Martingale Asset Management's PRTA Position: Q3 2026 in Review

Martingale Asset Management increased its Prothena (PRTA) stake by 6.7% in Q3 2026, buying an estimated $47.5K and bringing the position to 84,116 shares worth $705K. The position accounts for 0.02% of the portfolio, ranked #602.

Martingale Asset Management first reported a position in PRTA in Q1 2015 and has held it in 9 quarters since. The position peaked at $1.1M in Q2 2020. 182 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.

  • Martingale Asset Management held 84,116 shares of Prothena worth $705K as of Q3 2026.
  • Martingale Asset Management bought 5,316 Prothena shares in Q3 2026, an estimated $47.5K.
  • Prothena made up 0.02% of Martingale Asset Management's portfolio in Q3 2026, its #602 holding.
  • Martingale Asset Management first reported a position in Prothena in Q1 2015 and has held it in 9 quarters since.
  • Martingale Asset Management's Prothena position peaked at $1.1M in Q2 2020.
  • 182 funds tracked by Wall St. Rank held Prothena as of Q3 2026.

Based on Martingale Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.